Company / Capital Expenditures
Annexon, Inc. Capital Expenditures History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$15.0K
FY2024
5-year range
$15.0K / $6.5M
FY2020-FY2024
Trend
-92.2%
vs FY2023
Sector context
#185 of 192
Health Care
What the data says
Among 192 Health Care companies, Annexon, Inc. is in the bottom 4% for capital expenditures. Declined from $7M to $15,000 over the past 2 years.
Based on SEC 10-K filings.
$15,000 in FY2024 with a 5-year CAGR of -43.8%.
Declined from $7M to $15,000 over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -79.1%
- 5-Year CAGR
- -43.8%
- 10-Year CAGR
- -
Sector benchmark
Bottom 4% in Health CareTop 96% of 192This company $15.0K Sector average $118.6M
▼
-100.0% below sector average
Key checks
Key Insights
- 5-year CAGR of -43.8%, indicating a declining trend.
- In FY2024, capital expenditures decreased 92.2% year-over-year.
- Ranks #185 out of 192 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $15.0K | -92.2% |
| FY2023 | $193.0K | -97.0% |
| FY2022 | $6.5M | +294.6% |
| FY2021 | $1.7M | +256.5% |
| FY2020 | $464.0K | +73.8% |
| FY2019 | $267.0K | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026